MedPath

Effects of Shatavhadi Yog Basti in the Management ofAmavata

Phase 3
Conditions
Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Registration Number
CTRI/2023/06/053413
Lead Sponsor
Tilak Ayurved Mahavidyalaya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients between 18 to 60 years of age of either sex with clinical features of amavata mentioned in ayurvedic samhita i.e. Sandhishool, Sandhishotha, Sandhistabdhata, Sparshasahyatwa, Sandhi aushnya, Jwar and those who fulfill the - 2010: ACR and EULAR revised classification criteria for rheumatoid arthritis(18) are to be selected for the proposed study. Application of the newly revised criteria yields a score of 0-10. Those with the score > 6 fulfill the requirements for definite RA and a criterion for enrollment as a participant.

Exclusion Criteria

Chronicity of more than 5 years.

Having severe crippling deformity.

Patients having neoplasm of spine, gout, ankylosing spondylitis, traumatic arthritis, and pyogenic osteomyelitis.

Having cardiac disease, pulmonary tuberculosis and renal function impairment, diabetes mellitus and malignant hypertension.

Pregnant women and lactating mother.

Patients contraindicated for basti as mentioned in ayurvedic samhita.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Signs and symptoms of amavata (RA) | Subjective parameters <br/ ><br>a.Sandhishool (Pain) <br/ ><br>b.Sandhishotha (Swelling) <br/ ><br>c.Sandhistabdhata (Stiffness) <br/ ><br>d.Sparshasahyatwa (Tenderness) <br/ ><br>e.Sandhi aushnya (Warmth) <br/ ><br>f.Jwar (Fever) <br/ ><br>Timepoint: Day 1, Day 8, Day 14 and Day 21
Secondary Outcome Measures
NameTimeMethod
a.Serology : ESR and CRP <br/ ><br>b.Acute phase reactants : RF and ACPA <br/ ><br>Timepoint: Day 1 and Day 21
© Copyright 2025. All Rights Reserved by MedPath